Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
STAT3 Activation
100%
Liver Fibrosis Progression
100%
Hepatocytes
87%
Nonalcoholic Steatohepatitis
87%
P-STAT3
75%
Hepatic Progenitor Cells
75%
Liver Fibrosis
50%
Advanced Fibrosis
37%
Fibrosis
25%
Mortality Factors
25%
Liver Biopsy
25%
Sinusoidal Endothelial Cells
25%
Main Determinants
25%
STAT3 Inhibitor
25%
Spatial Distribution
25%
Fibrogenesis
25%
Spatial Transcriptomics
25%
Inflammation
12%
Hepatocellular Carcinoma
12%
Liver
12%
Innovative Technologies
12%
Severe Disease
12%
Immune-related Genes
12%
Deconvolution Analysis
12%
Correlation Analysis
12%
CD45
12%
STAT3 Signaling
12%
Transcriptomic Changes
12%
Gene Expression Changes
12%
Targeted Treatment
12%
Cancer Genes
12%
Cell Expansion
12%
Distribution Change
12%
Transcriptomic Profiling
12%
Spatial Dependence
12%
Cellular Deconvolution
12%
Medicine and Dentistry
Liver Fibrosis
100%
Nonalcoholic Fatty Liver
100%
Hepatocyte
50%
Hepatic Progenitor Cell
42%
Fibrosis
21%
Endothelial Cell
14%
Transcriptomics
14%
Liver Biopsy
14%
Fibrogenesis
14%
Malignant Neoplasm
7%
Gene Expression
7%
Prevalence
7%
Hepatocellular Carcinoma
7%
Immunity
7%
Targeted Therapy
7%
Cell Expansion
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Liver Fibrosis
100%
Fibrosis
21%
Malignant Neoplasm
7%
Liver Cell Carcinoma
7%
Inflammation
7%
Prevalence
7%
Biochemistry, Genetics and Molecular Biology
STAT3
100%
Hepatocyte
35%
Progenitor Cell
30%
Transcriptomics
10%
Fibrogenesis
10%
Gene Expression
5%
Prevalence
5%
Immunity
5%
Cell Expansion
5%